
    
      As specified by Phase 1 protocol-flexible language in the protocol, modifications to the dose
      or dosing regimen can be made to achieve the scientific goals of the trial objectives and/or
      ensure appropriate safety of the trial participants. The proposed doses for each Part may be
      adjusted downward based on evaluation of safety, tolerability, and pharmacokinetic data
      observed in previous panels.
    
  